Related Experiment Video
Updated: Mar 30, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
[Molecular tumour therapy]
C Michel1, A Neubauer1, A Burchert2
1Klinik für Innere Medizin, Schwerpunkt Hämatologie, Onkologie, Immunologie, Universitätsklinikum Gießen und Marburg, Standort Marburg, und Philipps-Universität, Baldingerstr. 1, 35043, Marburg, Deutschland.
Abstract:
In recent years, molecular tumour therapy has dramatically improved the treatment of various types of cancer. Molecular therapy is expected to attack malignant cells more specifically with fewer side effects than conventional chemotherapy. Both kinase inhibitors and monoclonal antibodies are key components of today's molecular cancer therapy. These substances cannot fully overcome the major tumour-biological problems, e.g. therapy resistance. However, as can be vividly seen with the example of immune checkpoint inhibitors, the rational design of molecularly designed drugs will considerably change therapeutic practice in oncology, albeit at the expense of exponentially growing health care costs.
Insights
Molecular tumour therapy offers targeted cancer treatment with fewer side effects than traditional chemotherapy. Advances in molecularly designed drugs, like immune checkpoint inhibitors, are transforming oncology but increase healthcare costs.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Context:
- Molecular tumour therapy has significantly advanced cancer treatment.
- Key components include kinase inhibitors and monoclonal antibodies.
- Challenges like therapy resistance persist in current molecular therapies.
Purpose:
- To review the advancements and challenges in molecular tumour therapy.
- To highlight the role of molecularly designed drugs in modern oncology.
- To discuss the impact of these therapies on cancer treatment and healthcare costs.
Summary:
- Molecular therapies target cancer cells more specifically, aiming for reduced side effects compared to conventional chemotherapy.
- Despite successes, overcoming tumour resistance remains a significant hurdle.
- The development of novel molecular drugs, exemplified by immune checkpoint inhibitors, is reshaping cancer care.
Impact:
- Molecularly designed drugs are revolutionizing oncological therapeutic practices.
- These targeted approaches offer improved specificity and potentially fewer side effects.
- The increasing efficacy of molecular therapies is associated with escalating healthcare expenditures.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
09:24Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing
Published on: June 9, 2016
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...